All In Biotech

Drug Trial Radar · NCT02612272

Comparing Intra-articular Corticosteroid to Intra-articular Ketorolac Knee Injections

A Double-blind, Randomized, Controlled, Equivalence Study Comparing Intra-articular Corticosteroid to Intra-articular Ketorolac Knee Injections

Last checked: Nov 20, 2026Latest source record: Oct 13, 2016 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknownPivotal-lookingRandomized with 448 participants. This is a heuristic, not a regulatory label.

Status

Status unknown

Enrollment

448

Planned (sponsor's estimate)

Start

Nov 2015

Primary completion

Oct 2017

Study completion Oct 2017

Sponsor

Lead sponsor
St. Luke's Hospital, PennsylvaniaAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Nov 23, 2015

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Double (participant, care provider)
Primary purpose
Treatment
Who can join
Male only, from 18 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This study will compare the efficacy of intra-articular betamethasone injection to intra-articular ketorolac injection for symptomatic treatment of knee osteoarthritis in an equivalence study using a double-blinded, randomized, controlled design. Patients will be recruited from orthopaedic clinics at St. Luke's University Health Network. A total of 448 patients will be recruited (224 in each group) to receive an administration of an intra-articular betamethasone or ketorolac injection. The primary outcome is change in pain as assessed by the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) score. Secondary outcomes include Knee Injury and Osteoarthritis Outcome (KOOS) and Knee Outcome Survey - Activities of Daily Living (KOS-ADL) scores and physical exam findings. Statistical analyses include repeated measures analysis of variance (ANOVA) (primary outcome) and selected ANOVA and nonparametric tests as deemed appropriate (secondary outcomes), with p \< .05 denoting significance for all comparisons, and no adjustment for multiple testing.

Conditions

  • Knee Osteoarthritis

Interventions

  • KetorolacDrug

    intra-articular ketorolac

  • BetamethasoneDrug

    intra-articular betamethasone

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)Time frame: Follow up at 1 month

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • St Luke's Health and University Network

    Bethlehem, Pennsylvania · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.